Last 12 months
Inside the activity.
1 purchase rows · 4 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 1 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 30, 2022 Filed Jul 1, 2022 23:41 UTC |
Barlow Jeff D.Chief Legal Officer
|
GrantCommon Stock | 78 | $279.61 | $21,809.58 |
DisclosureSEC source: 0001179929-22-000106 · wf-form4_165671884311471.xml · nonDerivative · entry 1 Barlow Jeff D. · CIK 0001555603 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,236 F1 · kind: The shares were acquired under the Molina Healthcare, Inc. 2019 Employee Stock Purchase Plan (the "ESPP"). F2 · price: Represents the closing price of Issuer's common stock on June 30, 2022. The purchase price is based on the stock's lower market price as of the two following dates: (1) January 1, 2022, the first day of the ESPP offering period, and (2) June 30, 2022, the last day of the ESPP offering period. F3 · balance_after: Shares shall vest as follows: 8,048 shares on March 1, 2023; 2,676 shares on March 1, 2024; and 1175 shares on March 1, 2025. The remaining shares are vested. Read SEC document |
| June 30, 2022 Filed Jul 1, 2022 23:40 UTC |
WOYS JAMESEVP, Health Plan Services
|
GrantCommon Stock | 78 | $279.61 | $21,809.58 |
DisclosureSEC source: 0001179929-22-000105 · wf-form4_165671881911294.xml · nonDerivative · entry 1 WOYS JAMES · CIK 0001213947 · EVP, Health Plan Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,810 F1 · kind: The shares were acquired under the Molina Healthcare, Inc. 2019 Employee Stock Purchase Plan (the "ESPP"). F2 · price: Represents the closing price of Issuer's common stock on June 30, 2022. The purchase price is based on the stock's lower market price as of the two following dates: (1) January 1, 2022, the first day of the ESPP offering period, and (2) June 30, 2022, the last day of the ESPP offering period. F3 · balance_after: Shares shall vest as follows: 5,066 shares shall vest on March 1, 2023; 2,889 shares shall vest on March 1, 2024; and 1,389 shares shall vest on March 1, 2025. The remaining shares are vested. Read SEC document |
| June 07, 2022 Filed Jun 8, 2022 00:59 UTC |
WOLF DALE BDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,000 | $33.02 Strike: $33.02 | $66,040.00 |
DisclosureSEC source: 0001179929-22-000086 · wf-form4_165464995891741.xml · derivative · entry 2 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 2,000 shares Expires 2023-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The options are fully vested. Read SEC document |
| June 07, 2022 Filed Jun 8, 2022 00:59 UTC |
WOLF DALE BDirector
|
Exercise / conversionCommon Stock | 2,000 | $33.02 | $66,040.00 |
DisclosureSEC source: 0001179929-22-000086 · wf-form4_165464995891741.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,630 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 06, 2022 Filed May 6, 2022 23:42 UTC |
ROMNEY RONNADirector
|
SaleCommon Stock | 200 | $307.94 | $61,588.00 |
DisclosureSEC source: 0001179929-22-000084 · wf-form4_165188054967348.xml · nonDerivative · entry 1 ROMNEY RONNA · CIK 0001206684 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by trust Disclosed balance after: 16,657 F1 · kind: The sale was made pursuant to Reporting Person's Rule 10b5-1 Trading Plan that was established on March 8, 2022. F2 · price: Represents the selling price per share of all 200 shares. F3 · ownership.nature: All shares held by Ronna Romney Revocable Trust. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 00:32 UTC |
BRASIER BARBARA LDirector
|
GrantCommon Stock | 162 | $339.41 | $54,984.42 |
DisclosureSEC source: 0001179929-22-000066 · wf-form4_164911855462080.xml · nonDerivative · entry 1 BRASIER BARBARA L · CIK 0001169490 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,815 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each Director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2022, the first day of the quarter, was $339.41, which resulted in a grant of 162 shares. F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2022. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 00:42 UTC |
Lockhart Stephen HDirector
|
GrantCommon Stock | 162 | $339.41 | $54,984.42 |
DisclosureSEC source: 0001179929-22-000074 · wf-form4_164911934556867.xml · nonDerivative · entry 1 Lockhart Stephen H · CIK 0001856013 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 881 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each Director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2022, the first day of the quarter, was $339.41, which resulted in a grant of 162 shares. F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2022 Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 00:42 UTC |
COOPERMAN DANIELDirector
|
GrantCommon Stock | 162 | $339.41 | $54,984.42 |
DisclosureSEC source: 0001179929-22-000073 · wf-form4_164911931945795.xml · nonDerivative · entry 1 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,416 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each Director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2022, the first day of the quarter, was $339.41, which resulted in a grant of 162 shares. F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2022. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 00:41 UTC |
ROMNEY RONNADirector
|
GrantCommon Stock | 162 | $339.41 | $54,984.42 |
DisclosureSEC source: 0001179929-22-000072 · wf-form4_164911910963294.xml · nonDerivative · entry 1 ROMNEY RONNA · CIK 0001206684 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by trust Disclosed balance after: 16,857 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each Director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2022, the first day of the quarter, was $339.41, which resulted in a grant of 162 shares. F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2022. F4 · ownership.nature: All shares held by Ronna Romney Revocable Trust. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 00:35 UTC |
ZORETIC RICHARD CDirector
|
GrantCommon Stock | 162 | $339.41 | $54,984.42 |
DisclosureSEC source: 0001179929-22-000069 · wf-form4_164911890449409.xml · nonDerivative · entry 1 ZORETIC RICHARD C · CIK 0001263714 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by trust Disclosed balance after: 5,086 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each Director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2022, the first day of the quarter, was $339.41, which resulted in a grant of 162 shares. F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2022. F4 · ownership.nature: All shares held by the Richard Charles Zoretic Revocable Living Trust. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 00:38 UTC |
Schapiro Richard MDirector
|
GrantCommon Stock | 162 | $339.41 | $54,984.42 |
DisclosureSEC source: 0001179929-22-000071 · wf-form4_164911901598451.xml · nonDerivative · entry 1 Schapiro Richard M · CIK 0001649773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,981 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each Director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2022, the first day of the quarter, was $339.41, which resulted in a grant of 162 shares. F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2022. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 00:36 UTC |
WOLF DALE BDirector
|
GrantCommon Stock | 162 | $339.41 | $54,984.42 |
DisclosureSEC source: 0001179929-22-000070 · wf-form4_164911893944249.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,630 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each Director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2022, the first day of the quarter, was $339.41, which resulted in a grant of 162 shares. F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2022. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 00:34 UTC |
Russo MarcEVP, Health Plans
|
Tax withholdingCommon Stock | 2,179 | $339.41 | $739,574.39 |
DisclosureSEC source: 0001179929-22-000068 · wf-form4_164911884083591.xml · nonDerivative · entry 1 Russo Marc · CIK 0001504606 · EVP, Health Plans 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,013 F1 · kind: The shares were applied to the payment of withholding taxes arising in connection with the vesting of 4,702 shares on April 1, 2022. F2 · price: Represents the closing price of the Issuer's common stock on April 1, 2022. F3 · balance_after: Shares shall vest as follows: 2,526 shares on each of March 1, 2023 and March 1, 2024; 1,175 shares on March 1, 2025, and an additional 4,701 shares on April 1, 2023. The remainder of the shares are vested. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 00:33 UTC |
ORLANDO STEVEN JDirector
|
GrantCommon Stock | 162 | $339.41 | $54,984.42 |
DisclosureSEC source: 0001179929-22-000067 · wf-form4_164911878888418.xml · nonDerivative · entry 1 ORLANDO STEVEN J · CIK 0001211493 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by trust Disclosed balance after: 20,571 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each Director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2022, the first day of the quarter, was $339.41, which resulted in a grant of 162 shares. F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2022. F4 · ownership.nature: Shares are held by Orlando Family Trust. Read SEC document |
| March 15, 2022 Filed Mar 16, 2022 22:55 UTC |
ROMNEY RONNADirector
|
SaleCommon Stock | 200 | $314.36 | $62,872.00 |
DisclosureSEC source: 0001179929-22-000052 · wf-form4_164747128804257.xml · nonDerivative · entry 1 ROMNEY RONNA · CIK 0001206684 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by trust Disclosed balance after: 16,695 F1 · price: Represents the actual selling price per share of all 200 shares. F2 · ownership.nature: All shares held by Ronna Romney Revocable Trust. Read SEC document |
| March 08, 2022 Filed Mar 9, 2022 00:57 UTC |
ORLANDO STEVEN JDirector
|
SaleCommon Stock | 591 | $311.00 | $183,801.00 |
DisclosureSEC source: 0001179929-22-000047 · wf-form4_164678742686353.xml · nonDerivative · entry 1 ORLANDO STEVEN J · CIK 0001211493 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by trust Disclosed balance after: 20,409 F1 · price: Represents the actual selling price per share of all 591 shares. F2 · ownership.nature: Shares are held by Orlando Family Trust. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 00:57 UTC |
Zubretsky Joseph MDirector · President & CEO
|
GiftCommon Stock | 1,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001179929-22-000048 · wf-form4_164678744764127.xml · nonDerivative · entry 1 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,157 F1 · kind: Reflects the gift of common stock to a charitable donor advised fund. F2 · price: Price not applicable to gift. F3 · balance_after: The shares shall vest as follows: 30,372 shares on March 1, 2023; 15,412 shares on March 1, 2024; 6,412 shares on March 1, 2025. The remainder of the shares are vested. Read SEC document |
| March 04, 2022 Filed Mar 4, 2022 23:56 UTC |
Barlow Jeff D.Chief Legal Officer
|
SaleCommon Stock | 5,000 | $315.00 | $1,575,000.00 |
DisclosureSEC source: 0001179929-22-000044 · wf-form4_164643816093840.xml · nonDerivative · entry 1 Barlow Jeff D. · CIK 0001555603 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,158 F1 · price: Represents the actual selling price per share of all 5,000 shares. F2 · balance_after: Shares shall vest as follows: 8,048 shares on March 1, 2023; 2,676 shares on March 1, 2024; and 1175 shares on March 1, 2025. The remaining shares are vested. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:31 UTC |
Russo MarcEVP, Health Plans
|
Tax withholdingCommon Stock | 626 | $311.88 | $195,236.88 |
DisclosureSEC source: 0001179929-22-000042 · wf-form4_164635747283969.xml · nonDerivative · entry 2 Russo Marc · CIK 0001504606 · EVP, Health Plans 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,192 F3 · kind: The shares were applied to the payment of withholding taxes arising in connection with the vesting of 1,350 shares on March 1, 2022. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2022. F4 · balance_after: Shares shall vest as follows: the 3,527 newly granted shares vest in one-third increments on each of March 1, 2023, March 1, 2024, and March 1, 2025. Additional shares shall vest as follows: 1,350 shares on each of March 1, 2023, and March 1, 2024; 4,702 shares on April 1, 2022 and 4,701 shares on April 1, 2023. The remainder of the shares are vested. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:31 UTC |
Russo MarcEVP, Health Plans
|
GrantCommon Stock | 3,527 | $311.88 | $1,100,000.76 |
DisclosureSEC source: 0001179929-22-000042 · wf-form4_164635747283969.xml · nonDerivative · entry 1 Russo Marc · CIK 0001504606 · EVP, Health Plans 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,818 F1 · kind: Grant of restricted stock under the Issuer's 2019 Equity Incentive Plan. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2022. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:31 UTC |
WOYS JAMESEVP, Health Plan Services
|
Tax withholdingCommon Stock | 6,342 | $311.88 | $1,977,942.96 |
DisclosureSEC source: 0001179929-22-000041 · wf-form4_164635745175299.xml · nonDerivative · entry 4 WOYS JAMES · CIK 0001213947 · EVP, Health Plan Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,732 F5 · kind: Shares were applied to payment of withholding taxes in connection with vesting of the above-mentioned performance stock units. F6 · balance_after: Shares shall vest as follows: the 4,168 newly granted shares vest in one-third increments on each of March 1, 2023, March 1, 2024, and March 1, 2025. Additional shares shall vest as follows: 3,676 shares on March 1, 2023, and 1,500 shares on March 1, 2024. The remaining shares are vested. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:31 UTC |
WOYS JAMESEVP, Health Plan Services
|
GrantCommon Stock | 17,342 | $311.88 | $5,408,622.96 |
DisclosureSEC source: 0001179929-22-000041 · wf-form4_164635745175299.xml · nonDerivative · entry 3 WOYS JAMES · CIK 0001213947 · EVP, Health Plan Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,074 F4 · kind: Shares issued in settlement of performance stock units granted in 2019 which vested at the 200% max level based on the achievement of cumulative net income metric over the three fiscal years of 2019, 2020 and 2021. F2 · price: Represents the closing price of the Issuer's common stock on March 1. 2022. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:31 UTC |
WOYS JAMESEVP, Health Plan Services
|
Tax withholdingCommon Stock | 2,206 | $311.88 | $688,007.28 |
DisclosureSEC source: 0001179929-22-000041 · wf-form4_164635745175299.xml · nonDerivative · entry 2 WOYS JAMES · CIK 0001213947 · EVP, Health Plan Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,732 F3 · kind: The shares were applied to the payment of withholding taxes arising in connection with the vesting of 5,602 shares on March 1, 2022. F2 · price: Represents the closing price of the Issuer's common stock on March 1. 2022. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:31 UTC |
WOYS JAMESEVP, Health Plan Services
|
GrantCommon Stock | 4,168 | $311.88 | $1,299,915.84 |
DisclosureSEC source: 0001179929-22-000041 · wf-form4_164635745175299.xml · nonDerivative · entry 1 WOYS JAMES · CIK 0001213947 · EVP, Health Plan Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,938 F1 · kind: Grant of restricted stock under the Issuer's 2019 Equity Incentive Plan. F2 · price: Represents the closing price of the Issuer's common stock on March 1. 2022. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:30 UTC |
Zubretsky Joseph MDirector · President & CEO
|
Tax withholdingCommon Stock | 55,157 | $311.88 | $17,202,365.16 |
DisclosureSEC source: 0001179929-22-000040 · wf-form4_164635742182823.xml · nonDerivative · entry 4 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,757 F5 · kind: Shares were applied to payment of withholding taxes in connection with vesting of the above-mentioned performance stock units. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2022. F6 · balance_after: The shares shall vest as follows: the 19,238 newly granted shares vest in one-third increments on each of March 1, 2023, March 1, 2024, and March 1, 2025. Additional shares shall vest as follows: 23,959 shares on March 1, 2023 and 8,999 on March 1, 2024. The remaining shares are vested. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:30 UTC |
Zubretsky Joseph MDirector · President & CEO
|
GrantCommon Stock | 112,718 | $311.88 | $35,154,489.84 |
DisclosureSEC source: 0001179929-22-000040 · wf-form4_164635742182823.xml · nonDerivative · entry 3 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 311,914 F4 · kind: Shares issued in settlement of performance stock units granted in 2019 which vested at the 200% max level based on the achievement of cumulative net income metric over the three fiscal years of 2019, 2020 and 2021. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2022. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:30 UTC |
Zubretsky Joseph MDirector · President & CEO
|
Tax withholdingCommon Stock | 17,704 | $311.88 | $5,521,523.52 |
DisclosureSEC source: 0001179929-22-000040 · wf-form4_164635742182823.xml · nonDerivative · entry 2 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,196 F3 · kind: The shares were applied to the payment of withholding taxes arising in connection with the vesting of 36,484 shares on March 1, 2022. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2022. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:30 UTC |
Zubretsky Joseph MDirector · President & CEO
|
GrantCommon Stock | 19,238 | $311.88 | $5,999,947.44 |
DisclosureSEC source: 0001179929-22-000040 · wf-form4_164635742182823.xml · nonDerivative · entry 1 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,900 F1 · kind: Grant of restricted stock under the Issuer's 2019 Equity Incentive Plan. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2022. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:30 UTC |
Barlow Jeff D.Chief Legal Officer
|
Tax withholdingCommon Stock | 7,969 | $311.88 | $2,485,371.72 |
DisclosureSEC source: 0001179929-22-000039 · wf-form4_164635739974265.xml · nonDerivative · entry 4 Barlow Jeff D. · CIK 0001555603 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,158 F5 · kind: Shares were applied to payment of withholding taxes in connection with vesting of the above-mentioned performance stock units. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2022. F6 · balance_after: Shares shall vest as follows: the 3,527 newly granted shares vest in one-third increments on each of March 1, 2023, March 1, 2024, and March 1, 2025. Additional shares shall vest as follows: 6,872 shares on March 1, 2023; and 1,500 shares on March 1, 2024. The remaining shares are vested. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:30 UTC |
Barlow Jeff D.Chief Legal Officer
|
GrantCommon Stock | 17,342 | $311.88 | $5,408,622.96 |
DisclosureSEC source: 0001179929-22-000039 · wf-form4_164635739974265.xml · nonDerivative · entry 3 Barlow Jeff D. · CIK 0001555603 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,127 F4 · kind: Shares issued in settlement of performance stock units granted in 2019 which vested at the 200% max level based on the achievement of cumulative net income metric over the three fiscal years of 2019, 2020 and 2021. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2022. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:30 UTC |
Barlow Jeff D.Chief Legal Officer
|
Tax withholdingCommon Stock | 4,021 | $311.88 | $1,254,069.48 |
DisclosureSEC source: 0001179929-22-000039 · wf-form4_164635739974265.xml · nonDerivative · entry 2 Barlow Jeff D. · CIK 0001555603 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,785 F3 · kind: The shares were applied to the payment of withholding taxes arising in connection with the vesting of 8,798 shares on March 1, 2022. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2022. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:30 UTC |
Barlow Jeff D.Chief Legal Officer
|
GrantCommon Stock | 3,527 | $311.88 | $1,100,000.76 |
DisclosureSEC source: 0001179929-22-000039 · wf-form4_164635739974265.xml · nonDerivative · entry 1 Barlow Jeff D. · CIK 0001555603 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,806 F1 · kind: Grant of restricted stock under the Issuer's 2019 Equity Incentive Plan. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2022. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:29 UTC |
HEBERT MAURICEChief Accounting Officer
|
Tax withholdingCommon Stock | 800 | $311.88 | $249,504.00 |
DisclosureSEC source: 0001179929-22-000038 · wf-form4_164635737475456.xml · nonDerivative · entry 4 HEBERT MAURICE · CIK 0001267043 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,333 F5 · kind: Shares were applied to payment of withholding taxes in connection with vesting of the above-mentioned performance stock units. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2022. F6 · balance_after: The shares shall vest as follows: the 1,202 newly granted shares vest in one-third increments on each of March 1, 2023, March 1, 2024, and March 1, 2025. Additional shares shall vest as follows: 902 shares on March 1, 2023; 631 shares on March 1, 2024; 253 shares on October 1, 2022. The remainder of the shares are vested. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:29 UTC |
HEBERT MAURICEChief Accounting Officer
|
GrantCommon Stock | 2,168 | $311.88 | $676,155.84 |
DisclosureSEC source: 0001179929-22-000038 · wf-form4_164635737475456.xml · nonDerivative · entry 3 HEBERT MAURICE · CIK 0001267043 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,133 F4 · kind: Shares issued in settlement of performance stock units granted in 2019 which vested at the 200% max level based on the achievement of cumulative net income metric over the three fiscal years of 2019, 2020 and 2021. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2022. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:29 UTC |
HEBERT MAURICEChief Accounting Officer
|
Tax withholdingCommon Stock | 267 | $311.88 | $83,271.96 |
DisclosureSEC source: 0001179929-22-000038 · wf-form4_164635737475456.xml · nonDerivative · entry 2 HEBERT MAURICE · CIK 0001267043 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,965 F3 · kind: The shares were applied to the payment of withholding taxes arising in connection with the vesting of 903 shares on March 1, 2022. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2022. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:29 UTC |
HEBERT MAURICEChief Accounting Officer
|
GrantCommon Stock | 1,202 | $311.88 | $374,879.76 |
DisclosureSEC source: 0001179929-22-000038 · wf-form4_164635737475456.xml · nonDerivative · entry 1 HEBERT MAURICE · CIK 0001267043 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,232 F1 · kind: Grant of restricted stock under the Issuer's 2019 Equity Incentive Plan. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2022. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:29 UTC |
Keim Mark LowellChief Financial Officer
|
Tax withholdingCommon Stock | 7,211 | $311.88 | $2,248,966.68 |
DisclosureSEC source: 0001179929-22-000037 · wf-form4_164635735496454.xml · nonDerivative · entry 4 Keim Mark Lowell · CIK 0001690677 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,813 F5 · kind: Shares were applied to payment of withholding taxes in connection with vesting of the above-mentioned performance stock units. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2022. F6 · balance_after: The shares shall vest as follows: the 4,810 newly granted shares vest in one-third increments on each of March 1, 2023, March 1, 2024, and March 1, 2025. Additional shares vest as follows: 4,820 shares on March 1, 2023; and 2,100 shares on March 1, 2024. The remaining shares are vested. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:29 UTC |
Keim Mark LowellChief Financial Officer
|
GrantCommon Stock | 17,342 | $311.88 | $5,408,622.96 |
DisclosureSEC source: 0001179929-22-000037 · wf-form4_164635735496454.xml · nonDerivative · entry 3 Keim Mark Lowell · CIK 0001690677 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,024 F4 · kind: Shares issued in settlement of performance stock units granted in 2019 which vested at the 200% max level based on the achievement of cumulative net income metric over the three fiscal years of 2019, 2020 and 2021. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2022. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:29 UTC |
Keim Mark LowellChief Financial Officer
|
Tax withholdingCommon Stock | 2,994 | $311.88 | $933,768.72 |
DisclosureSEC source: 0001179929-22-000037 · wf-form4_164635735496454.xml · nonDerivative · entry 2 Keim Mark Lowell · CIK 0001690677 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,682 F3 · kind: The shares were applied to the payment of withholding taxes arising in connection with the vesting of 6,746 shares on March 1, 2022. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2022. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:29 UTC |
Keim Mark LowellChief Financial Officer
|
GrantCommon Stock | 4,810 | $311.88 | $1,500,142.80 |
DisclosureSEC source: 0001179929-22-000037 · wf-form4_164635735496454.xml · nonDerivative · entry 1 Keim Mark Lowell · CIK 0001690677 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,676 F1 · kind: Grant of restricted stock under the Issuer's 2019 Equity Incentive Plan. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2022. Read SEC document |
| February 23, 2022 Filed Feb 23, 2022 23:49 UTC |
ROMNEY RONNADirector
|
SaleCommon Stock | 105 | $307.97 | $32,336.81 |
DisclosureSEC source: 0001179929-22-000030 · wf-form4_164566012736438.xml · nonDerivative · entry 2 ROMNEY RONNA · CIK 0001206684 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by trust Disclosed balance after: 16,895 F1 · kind: The sales were made pursuant to Reporting Person's Rule 10b5-1 Trading Plan that was established on February 16, 2021. F4 · price: Represents the actual selling price per share of all 105 shares. F3 · ownership.nature: All shares held by Ronna Romney Revocable Trust. Read SEC document |
| February 22, 2022 Filed Feb 23, 2022 23:49 UTC |
ROMNEY RONNADirector
|
SaleCommon Stock | 195 | $313.21 | $61,075.95 |
DisclosureSEC source: 0001179929-22-000030 · wf-form4_164566012736438.xml · nonDerivative · entry 1 ROMNEY RONNA · CIK 0001206684 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by trust Disclosed balance after: 17,000 F1 · kind: The sales were made pursuant to Reporting Person's Rule 10b5-1 Trading Plan that was established on February 16, 2021. F2 · price: Represents the actual selling price per share of all 195 shares. F3 · ownership.nature: All shares held by Ronna Romney Revocable Trust. Read SEC document |
| January 10, 2022 Filed Jan 12, 2022 01:14 UTC |
Keim Mark LowellChief Financial Officer
|
Tax withholdingCommon Stock | 1,325 | $289.70 | $383,852.50 |
DisclosureSEC source: 0001179929-22-000018 · wf-form4_164195006843425.xml · nonDerivative · entry 1 Keim Mark Lowell · CIK 0001690677 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,866 F1 · kind: The shares were applied to the payment of withholding taxes arising in connection with the vesting of 2,939 shares on January 10, 2022. F2 · price: Represents the closing price of the Issuer's common stock on January 10, 2022. F3 · balance_after: Shares shall vest as follows: 6,746 shares on March 1, 2022; 4,820 shares on March 1, 2023; and 2,100 shares on March 1, 2024. The remaining shares are vested. Read SEC document |
| January 01, 2022 Filed Jan 4, 2022 00:30 UTC |
BRASIER BARBARA LDirector
|
GrantCommon Stock | 173 | $318.08 | $55,027.84 |
DisclosureSEC source: 0001179929-22-000013 · wf-form4_164125622527222.xml · nonDerivative · entry 1 BRASIER BARBARA L · CIK 0001169490 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,653 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2022 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 31, 2021, of $318.08. Thus, the grant this quarter for services as a Director is for 173 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on December 31, 2021. Read SEC document |
| January 01, 2022 Filed Jan 4, 2022 00:31 UTC |
COOPERMAN DANIELDirector
|
GrantCommon Stock | 173 | $318.08 | $55,027.84 |
DisclosureSEC source: 0001179929-22-000015 · wf-form4_164125625694179.xml · nonDerivative · entry 1 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,254 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2022 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 31, 2021, of $318.08. Thus, the grant this quarter for services as a Director is for 173 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on December 31, 2021. Read SEC document |
| January 01, 2022 Filed Jan 4, 2022 00:31 UTC |
Lockhart Stephen HDirector
|
GrantCommon Stock | 173 | $318.08 | $55,027.84 |
DisclosureSEC source: 0001179929-22-000016 · wf-form4_164125627416608.xml · nonDerivative · entry 1 Lockhart Stephen H · CIK 0001856013 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 719 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2022 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 31, 2021, of $318.08. Thus, the grant this quarter for services as a Director is for 173 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on December 31, 2021. Read SEC document |
| January 01, 2022 Filed Jan 4, 2022 00:30 UTC |
ZORETIC RICHARD CDirector
|
GrantCommon Stock | 173 | $318.08 | $55,027.84 |
DisclosureSEC source: 0001179929-22-000014 · wf-form4_164125624097235.xml · nonDerivative · entry 1 ZORETIC RICHARD C · CIK 0001263714 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by trust Disclosed balance after: 4,924 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2022 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 31, 2021, of $318.08. Thus, the grant this quarter for services as a Director is for 173 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on December 31, 2021. F4 · ownership.nature: All shares held by the Richard Charles Zoretic Revocable Living Trust. Read SEC document |
| January 01, 2022 Filed Jan 4, 2022 00:30 UTC |
ORLANDO STEVEN JDirector
|
GrantCommon Stock | 173 | $318.08 | $55,027.84 |
DisclosureSEC source: 0001179929-22-000012 · wf-form4_164125620884072.xml · nonDerivative · entry 1 ORLANDO STEVEN J · CIK 0001211493 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by trust Disclosed balance after: 21,000 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2022 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 31, 2021, of $318.08. Thus, the grant this quarter for services as a Director is for 173 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on December 31, 2021. F4 · ownership.nature: Shares are held by Orlando Family Trust. Read SEC document |
| January 01, 2022 Filed Jan 4, 2022 00:30 UTC |
WOLF DALE BDirector
|
GrantCommon Stock | 173 | $318.08 | $55,027.84 |
DisclosureSEC source: 0001179929-22-000011 · wf-form4_164125619295690.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,468 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2022 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 31, 2021, of $318.08. Thus, the grant this quarter for services as a Director is for 173 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on December 31, 2021. Read SEC document |
| January 01, 2022 Filed Jan 4, 2022 00:29 UTC |
Schapiro Richard MDirector
|
GrantCommon Stock | 173 | $318.08 | $55,027.84 |
DisclosureSEC source: 0001179929-22-000010 · wf-form4_164125616738502.xml · nonDerivative · entry 1 Schapiro Richard M · CIK 0001649773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,819 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2022 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 31, 2021, of $318.08. Thus, the grant this quarter for services as a Director is for 173 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on December 31, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.